3649 results for «2333»
3649 results
New insights into pharmacological treatment for STEMI
21 May 2026 – From EuroPCR 2026
This session presents the latest pharmacological advances in the treatment of ST-segment elevation myocardial infarction (STEMI). It covers safety data on ticagrelor monotherapy post-primary PCI, the impact of P2Y12 inhibitor pretreatment, effects of dapagliflozin on myocardial remodeling, and considerations for bleeding risk and vascular preparation strategies...
CT and intracoronary imaging evaluation of coronary disease
21 May 2026 – From EuroPCR 2026
This session focuses on advanced imaging modalities for evaluating coronary artery disease, including the clinical application of CT angiography and intracoronary imaging techniques like OCT and IVUS. Topics encompass barriers to OCT usage, the impact of plaque composition on PCI outcomes, advances in photon-counting CT technology,...
Left main complications - Part 2
21 May 2026 – From EuroPCR 2026
This session covers intricate complications involving the left main coronary artery (LMCA), highlighting cases of catheter-induced dissections, challenges in chronic total occlusion (CTO) PCI, and rare scenarios such as stent entrapment and complex re-interventions. Emphasis is placed on the critical utility of intravascular ultrasound (IVUS) and...
Pharmacology without borders, from coronary artherostenosis to radial artery
21 May 2026 – From EuroPCR 2026
This session delves into the expansive role of pharmacology in interventional cardiology, addressing topics ranging from coronary atherostenosis to radial artery management. Key discussions include the real-world efficacy and safety of intravenous cangrelor-assisted PCI in chronic coronary syndromes, comparative analysis of intra-arterial verapamil versus placebo for...
Stay calm and carry on: bailout techniques for calcified lesions
20 May 2026 – From EuroPCR 2026
Focused on bailout techniques for calcified lesions, this session addresses challenging scenarios such as deformed stents, post-CABG angioplasty complications, and balloon uncrossable lesions in tortuous anatomy. It provides practical approaches to manage complex calcium-related complications that may arise unexpectedly during intervention, ensuring preparedness for difficult procedural...
Controversies and conversations in TAVI
21 May 2026 – From EuroPCR 2026
This session addresses key controversies and discussions in transcatheter aortic valve implantation (TAVI), including the role of invasive coronary angiography prior to TAVI, use of cangrelor during combined TAVI and high-risk PCI, and discrepancies in aortic valve stenosis assessment methods. Additional topics cover operator models, valve...
Bifurcation and heavily calcified lesions
21 May 2026 – From EuroPCR 2026
This session addresses the evaluation and treatment of bifurcation and heavily calcified coronary lesions. It includes case-based discussions on complex left main PCI and the use of drug-coated balloons (DCB) for bifurcation lesions and in-stent restenosis, providing evidence-based approaches to optimize outcomes in these challenging lesion...
Bifurcation failure: the realities and strategies for avoidance
21 May 2026 – From EuroPCR 2026
This session addresses the challenges associated with bifurcation lesion PCI, focusing on procedural complications, novel classification systems for in-stent restenosis, and plaque characterization near side branches. It reviews clinical outcomes of Drug-Coated Balloon (DCB) treatments for side branch lesions, the influence of drug-eluting balloon strategies, and...
Strategies to enhance bifurcation PCI outcomes
21 May 2026 – From EuroPCR 2026
This session addresses strategies to optimize outcomes in coronary bifurcation PCI. It evaluates the impact of cutting and scoring balloons versus non-compliant balloons on stent expansion, predictors of target vessel revascularization using the POKI technique, and compares stent and non-stent approaches in side branch myocardial infarction...
SCAD, PCI specific strategies
21 May 2026 – From EuroPCR 2026
This session focuses on specific percutaneous coronary intervention strategies for spontaneous coronary artery dissection (SCAD) and related coronary anomalies. It covers clinical and therapeutic aspects of adult coronary aneurysms, woven coronary anomalies, innovative stent optimization techniques, microvascular dysfunction in takotsubo syndrome, and real-world management of SCAD...
Aortic stenosis: from diagnostic to treatment
21 May 2026 – From EuroPCR 2026
This session provides an in-depth review of contemporary management of aortic stenosis, covering diagnostic advancements, temporal trends, and treatment outcomes. It includes insights from the LAPLACE-TAVI registry focusing on low-risk patients, discusses the growing feasibility of day-case TAVI procedures, compares transcatheter and surgical valve replacements in...
Complication management after tricuspid valve interventions
21 May 2026 – From EuroPCR 2026
This session reviews complication management following tricuspid valve interventions, highlighting practical approaches to unexpected procedural events. Topics include management of TricValve pop-up complications, Evoque device challenges, acute leaflet thrombosis emergencies, and bailout strategies for single leaflet detachment in tricuspid transcatheter edge-to-edge repair (TEER).
Focus on heart failure: from acute to chronic
21 May 2026 – From EuroPCR 2026
This comprehensive session delves into the spectrum of heart failure management, from acute presentations to chronic conditions. Key topics include the cardio-hepatic syndrome and right ventricular dysfunction in HFmrEF, prognostic implications of heart failure etiologies, and innovative approaches such as AI-assisted echocardiography for early detection of...
A series of complex real-word challenges STEMI treatment from very different countries
21 May 2026 – From EuroPCR 2026
This session showcases a series of complex STEMI treatment challenges from diverse international settings, highlighting difficult coronary anatomies and complicated procedures. It discusses nuanced clinical scenarios where artery recanalisation does not always equate to reperfusion, and presents stepwise approaches to managing multivessel disease, renal failure, and...
Case-based challenges and dilemmas in multivessel PCI
21 May 2026 – From EuroPCR 2026
This session addresses real-world challenges in multivessel PCI for stable and acute coronary syndromes, emphasizing decision-making, procedure planning, and complication management. It highlights the application of imaging, physiology, and contemporary tools such as DCB to optimize outcomes through illustrative cases from Bangladesh, Brunei Darussalam, and the...
Complication management during STEMI intervention: Czech Republic - Greece and Iraq present their cases
21 May 2026 – From EuroPCR 2026
This session presents a critical analysis of procedural strategies in primary PCI for STEMI by exploring complex cases from the Czech Republic, Greece, and Iraq. It delves into mechanisms and management of major PCI complications and highlights the role of emerging novel technologies in primary PCI...
Diagnosis and management of INOCA and ANOCA
21 May 2026 – From EuroPCR 2026
This session focuses on the diagnosis and management of ischemia and angina with non-obstructive coronary arteries (INOCA and ANOCA). It presents safety data from coronary function testing, patient outcomes after comprehensive ischemia assessment, and endotype-specific treatment effects. Further topics include coronary sinus reducer therapy, the impact...
Mitral interventions: procedural risk assessment and interventions
21 May 2026 – From EuroPCR 2026
Focused on mitral valve interventions, this session covers procedural risk assessment and outcomes following transcatheter edge-to-edge repair (TEER). Topics include predictive risk scores, technical complexity, pulmonary artery pressure indices, right ventricle-pulmonary artery coupling, and novel imaging predictors influencing procedural success and patient prognosis.
TAVI procedural complications - Part 9: coronary occlusion, difficult aortic valve crossing and more
21 May 2026 – From EuroPCR 2026
Explore the management of complex TAVI procedural complications, including coronary occlusion and difficult valve crossing. This session presents innovative bailout techniques, diagnostic challenges, and case-based discussions highlighting acute coronary syndrome post-TAVI and nuanced approaches to valve-in-valve interventions.
When anatomy surprises: closing rare fistulae
21 May 2026 – From EuroPCR 2026
This session focuses on the percutaneous closure of rare and complex cardiac fistulae and related vascular anomalies. It presents diverse cases such as superior vena cava syndrome from pacemaker leads, iatrogenic aorta-to-left atrium fistula, and unusual cardio-pulmonary connections, illustrating advanced interventional techniques to address unexpected anatomical...